To identify clinical characteristics of the three subtypes of diffuse glioma, we examined conventional clinical variables, including age, gender, tumor grade, IDH mutation status, 1p19q codeletion status, and MGMT promoter status in TCGA cohort. This evidence concerns the gene IDH1 and neoplasm.